Back to dashboard
MedicaidCoverageMedium impact

Policy Updates and Changes to Clinical Review Criteria pdf

Connecticut Medicaid (HUSKY Health)·CT · Neurology, Nephrology, Pulmonology +1 more·Provider Bulletin
Effective date
Jul 1, 2021
We identified it
Jun 20, 2026
Days to comply

Summary

Connecticut Medicaid has introduced new coverage policies for three specialized medical devices/treatments effective July 1, 2021, including OXLUMO for primary hyperoxaluria, Volara System for lung therapy, and Kinova robotic arm for mobility assistance. Additionally, clinical criteria were updated for Spinraza and Zolgensma treatments.

Action Required

Action needed
By July 1, 2021: Billing team must implement prior authorization requirements for OXLUMO (lumasiran), Volara System, and Kinova JACO robotic arm claims. Update billing system to flag these services for case-by-case review process. Contact CHNCT at 1-800-440-5071 for prior authorization questions. Review updated Authorization Request Forms and clinical criteria for Spinraza and Zolgensma on the HUSKY Health portal.